课题基金 / 基金详情

ANNULATED PYRANSIDES FOR OPTICALLY ACTIVE POLYQUINANES

ANNULATED PYRANSIDES FOR OPTICALLY ACTIVE POLYQUINANES
光学活性聚喹烷的环状吡喃酯
批准号:
3292675
负责人:
Bertram Oliver Fraser-Reid
金额:
$15.25万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1983
资助国家:
美国
项目状态:
已结题
起止时间:
1983-03-01 至 1991-06-30

项目摘要

项目成果

Bertram Oliver Fraser-Reid的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Actinobolin and bactinobolin are congeners that are closely structurally related. However, their biological activities are most dissimilar. Actinobolin was for several years widely investigated, but its prospects as an antibiotic were not encouraging. However, much interest currently centers around its use for oral hygiene in preventing the formation of dental caries. Bactinobolin, on the other hand, is a promising antitumor agent, being up to one-thousand times more potent than actinobolin. Our synthetic plan is to prepare actinobolin in optically active form from a carbohydrate precursor. We intend to take advantage of our observation that in "annulated pyranosides", the anomeric effect operating in the pyranoside moiety, controls the conformation of the entire assembly. Thus stereocontrolled transformations can be carried out on the "annulus". Allied studies will be undertaken to help amplify and clarify qualitative and quantitative aspects of the anomeric effect. These will extend to theoretical studies to be undertaken jointly with Professor Dennis Liotta. Actinobolin is to be synthesized first and minor changes at late stages of the synthetic plan will enable us to achieve bactinobolin. Relay studies from actinobolin itself will influence our synthetic design.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Laboratory Syntheses of Mycobacterial tuberculosis LAM Prototypes
PENTENYL GLYCOSIDES--TRANSFORMATIONS AT ANOMERIC CENTER
PENTENYL GLYCOSIDES--TRANSFORMATIONS AT ANOMERIC CENTER
PENTENYL GLYCOSIDES--TRANSFORMATIONS AT ANOMERIC CENTER